Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | STEMVAC |
Trade Name | |
Synonyms | CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope plasmid DNA vaccine |
Drug Descriptions |
STEMVAC is a cancer vaccine that encodes multiple class II epitopes that result in a Th1 response upon expression, potentially leading to enhanced antitumor immune response (Journal for ImmunoTherapy of Cancer 2022;10, NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C116321 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Sargramostim + STEMVAC | STEMVAC Sargramostim | 0 | 2 |
STEMVAC | STEMVAC | 0 | 0 |